1. Home
  2. SAVA vs WKEY Comparison

SAVA vs WKEY Comparison

Compare SAVA & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • WKEY
  • Stock Information
  • Founded
  • SAVA 1998
  • WKEY 1999
  • Country
  • SAVA United States
  • WKEY Switzerland
  • Employees
  • SAVA N/A
  • WKEY N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • WKEY EDP Services
  • Sector
  • SAVA Health Care
  • WKEY Technology
  • Exchange
  • SAVA Nasdaq
  • WKEY Nasdaq
  • Market Cap
  • SAVA 70.5M
  • WKEY 74.5M
  • IPO Year
  • SAVA N/A
  • WKEY N/A
  • Fundamental
  • Price
  • SAVA $2.35
  • WKEY $6.00
  • Analyst Decision
  • SAVA Buy
  • WKEY Strong Buy
  • Analyst Count
  • SAVA 2
  • WKEY 1
  • Target Price
  • SAVA $54.50
  • WKEY $4.00
  • AVG Volume (30 Days)
  • SAVA 1.2M
  • WKEY 139.6K
  • Earning Date
  • SAVA 08-07-2025
  • WKEY 08-05-2025
  • Dividend Yield
  • SAVA N/A
  • WKEY N/A
  • EPS Growth
  • SAVA N/A
  • WKEY N/A
  • EPS
  • SAVA N/A
  • WKEY N/A
  • Revenue
  • SAVA N/A
  • WKEY $11,875,000.00
  • Revenue This Year
  • SAVA N/A
  • WKEY $18.18
  • Revenue Next Year
  • SAVA N/A
  • WKEY $112.51
  • P/E Ratio
  • SAVA N/A
  • WKEY N/A
  • Revenue Growth
  • SAVA N/A
  • WKEY N/A
  • 52 Week Low
  • SAVA $1.15
  • WKEY $1.61
  • 52 Week High
  • SAVA $42.20
  • WKEY $14.00
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 56.89
  • WKEY 46.74
  • Support Level
  • SAVA $2.11
  • WKEY $5.79
  • Resistance Level
  • SAVA $2.72
  • WKEY $6.93
  • Average True Range (ATR)
  • SAVA 0.16
  • WKEY 0.38
  • MACD
  • SAVA 0.04
  • WKEY -0.04
  • Stochastic Oscillator
  • SAVA 52.56
  • WKEY 23.24

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

Share on Social Networks: